Fine Foods & Pharmaceuticals N.T.M. S.p.A. / Fundamentals
Income statement
- Net revenue
€249.65M - Cost of goods sold
€145.68M - Gross profit
€103.97M - SG&A expenses
€1.47M - R&D expenses
€0.00 - EBITDA
€35.36M - D&A
€15.84M - EBIT
€18.87M - Interest expenses
€2.73M - EBT
€16.79M - Tax expenses
€4.35M - Net income
€12.44M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€5.38M - Changes in working capital
€3.24M - Operating cash flow
€36.90M - Capex
€41.59M - Other investing cash flow
€2.54M - Net investing cash flow
-€38.31M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€17.32M - Other financing cash flow
€25.67M - Net financing cash flow
€8.11M - Foreign exchange effects
€0.00 - Net change in cash
€6.70M - Cash at end of period
€21.90M - Free cash flow
€78.49M
Balance sheet
- Cash and cash equivalents
€21.90M - Cash and short-term investments
€21.90M - Total receivables
€46.60M - Inventory
€41.00M - Other current assets
€4.89M - Total current assets
€114.40M - Property, plant & equipment
€140.84M - Goodwill
€11.51M - Intangible assets
€1.72M - Long-term investments
€0.00 - Other non-current assets
€124.75K - Total non-current assets
€155.87M - Total assets
€270.27M - Accounts payable
€38.51M - Short-term debt
€13.28M - Other current liabilities
€15.26M - Total current liabilities
€68.39M - Long-term debt
€60.25M - Deferred tax liabilities
€292.35K - Other non-current liabilities
€4.17M - Total non-current liabilities
€64.71M - Total liabilities
€133.10M - Common stock
€22.77M - Retained earnings
€9.57M - Other equity
€0.00 - Total equity
€137.16M - Total liabilities and shareholders' equity
€270.27M
Company information
- Market capitalization
€190.74M - Employees
779 - Enterprise Value
€216.19M
Company ratios
- Gross margin
-
41.6% Better than peer group: 28.9% - EBITDA margin
-
14.2% Even with peer group: 17.0% - EBIT margin
-
7.6% Worse than peer group: 13.8% - EBT margin
-
6.7% Worse than peer group: 13.8% - Net margin
-
5.0% Worse than peer group: 10.2% - ROE
-
9.1% Worse than peer group: 21.3% - ROA
-
4.6% Worse than peer group: 11.6% - Asset turnover
-
92.4% Much worse than peer group: 136.0% - FCF margin
-
-1.9% Worse than peer group: 5.7% - FCF yield
-2.5% - Efficiency ratio
85.8% - Net sales per employee
-
€320.47K - Net income per employee
-
€15.97K